Posts Tagged ‘Jie Liu’

Using carbon nanotubes to treat neural injuries?

Tuesday, December 11th, 2012

It’s more usual to hear about toxicology when discussing carbon nanotubes (CNTs) and health but recent work from Duke University Medical Center suggests that CNTs could be used in therapeutic treatments for neural injuries. From the Dec. 10,2012 news item on ScienceDaily,

A nanomaterial engineered by researchers at Duke can help regulate chloride levels in nerve cells that contribute to chronic pain, epilepsy, and traumatic brain injury.

The findings, published online Dec. 10, 2012, in the journal Small, were demonstrated in individual nerve cells as well as in the brains of mice and rats, and may have future applications in intracranial or spinal devices to help treat neural injuries.

The Dec. 10, 2012 news release from Duke Medicine News and Communications discusses carbon nanotubes and the applications they are usually associated with,

Carbon nanotubes are a nanomaterial with unique features, including mechanical strength and electrical conductivity. These characteristics, along with their tiny size, make them appealing to researchers in technology and medicine alike.

In a world of shrinking computers and smartphones, carbon nanotubes have been tapped as a solution for improving microchips. They outpace silicon microchips in size and performance, meeting a demand for smaller, faster devices. For people with nerve injury and certain neurological disorders, devices coated with or entirely made of carbon nanotubes could offer a new avenue for improving treatment options.

“Carbon nanotubes hold great promise for an array of applications, and we are only beginning to see their enormous potential,” said lead author Wolfgang Liedtke, M.D., PhD, associate professor of medicine and neurobiology at Duke. “Their exceptional mechanical and electrical properties make them ideal for developing devices that interface with nervous tissues. However, the precise mechanisms behind carbon nanotubes and their effect on neurons remain elusive.”

One of the Duke researchers actually developed a new kind of carbon nanotube for this research (from the Duke news release),

Not all carbon nanotubes are the same. Jie Liu, PhD, George Barth Geller Professor of Chemistry at Duke University and senior author of the study, developed specific carbon nanotubes that are extraordinarily pure. Termed few-walled carbon nanotubes, they have superior properties to their commercially-available counterparts.

Duke researchers initially set out to gauge if carbon nanotubes had toxic or adverse effects on living tissue. Studying neurons cultured from rodents, representing a “cerebral cortex in a dish,” they found the opposite. Exposing the cells to carbon nanotubes appeared to have a nourishing effect on the neurons, making them bigger and stronger.

“Previous studies have looked at the behavior of carbon nanotubes on neurons. However, the impurity in the nanotubes significantly affected the results. After we developed pure few-walled carbon nanotubes in our lab, we discovered that nanotubes actually accelerated the growth of the neuronal cells significantly,” said Liu.

Here’s what happens in some cases of neural injury and the impact that few-walled carbon nanotubes might have on future therapeutics (from the Duke news release),

Neural circuits can be corrupted by elevated chloride within neurons. A number of diseases involve such neural circuit damage, including chronic pain, epilepsy, and traumatic brain injury.

Low levels of chloride within neurons are maintained by a chloride transporter protein called KCC2, which functions by churning chloride ions out of the cell. In mature neurons, there is no back-up for this function.

The immature neurons cultured in Liedtke’s laboratory had high levels of chloride, but as the cells matured, their chloride levels dropped as KCC2 increased. When the neurons were exposed to carbon nanotubes, the cells matured much faster, and the chloride levels dropped more quickly. Researchers learned that younger cells exposed to carbon nanotubes produced more KCC2 protein.

“Carbon nanotubes enhanced the regulation of chloride in neurons to normal levels. These changes are of enormous significance to the cell,” Liedtke said.

The increase in KCC2 protein was also connected to a rise in calcium in the neurons. The increased calcium levels activated a protein found in the brain called CaMKII which signals a neuron to make more KCC2.

Similar results were observed in the brains of mice, as the carbon nanotubes prompted an increase in activity of the KCC2 gene, suggesting that the few-walled carbon nanotubes influence gene regulation of KCC2.

These findings may lead to the development of a new generation of neural engineering devices using carbon nanotubes. Existing devices that modulate the function of nerve cells use electrical systems that date back several decades.

“We hope that carbon nanotubes will work as well in injured nerves as they did in our study of developing neurons,” Liedtke continued. “The use of carbon nanotubes is just in its infancy, and we are excited to be part of a developing field with so much potential.”

Naturally (sarcasm alert), the researchers have done this (from the Duke news release),

Liedtke and Liu have filed a preliminary patent application for the few-walled carbon nanotubes used in this research. [emphasis mine]

How how many new therapies will be developed (or even researched) if the materials needed for the research are patented?

For anyone who’s interested in the paper, here’s a citation and link (from the ScienceDaily news item),

Wolfgang Liedtke, Michele Yeo, Hongbo Zhang, Yiding Wang, Michelle Gignac, Sara Miller, Ken Berglund and Jie Liu. Highly Conductive Carbon Nanotube Matrix Accelerates Developmental Chloride Extrusion in Central Nervous System Neurons by Increased Expression of Chloride Transporter KCC2. Small, 10 DEC 2012 DOI: 10.1002/smll.201201994

This paper is behind a paywall.

It should be mentioned that ScienceDaily offers a choice of citation formats, APA or MLA. This citation is in APA format.

Brain-controlled robotic arm means drinking coffee by yourself for the first time in 15 years

Thursday, May 17th, 2012

The video shows a woman getting herself a cup of coffee for the first time in 15 years. She’s tetraplegic (aka quadraplegic) and is participating in a research project funded by DARPA (US Defense Advanced Research Projects Agency) for developing neuroprostheses.

Kudos to the researchers and to the woman for her courage and persistence. The May 17, 2012 news item on Nanowerk provides some background,

DARPA launched the Revolutionizing Prosthetics program in 2006 to advance the state of upper-limb prosthetic technology with the goals of improving quality of life for service-disabled veterans and ultimately giving them the option of returning to duty. [emphasis mine] Since then, Revolutionizing Prosthetics teams have developed two anthropomorphic advanced modular prototype prosthetic arm systems, including sockets, which offer increased range of motion, dexterity and control options. Through DARPA-funded work and partnerships with external researchers, the arm systems and supporting technology continue to advance.

The newest development on this project (Revolutionizing Prosthetics) comes from the BrainGate team (mentioned in my April 19, 2012 posting [scroll down about 1/5th of the way) many of whom are affiliated with Brown University.  Alison Abbott’s May 16, 2012 Nature article provides some insight into the latest research,

The study participants — known as Cathy and Bob — had had strokes that damaged their brain stems and left them with tetraplegia and unable to speak. Neurosurgeons implanted tiny recording devices containing almost 100 hair-thin electrodes in the motor cortex of their brains, to record the neuronal signals associated with intention to move.

The work is part of the BrainGate2 clinical trial, led by John Donoghue, director of the Brown Institute for Brain Science in Providence. His team has previously reported a trial in which two participants were able to move a cursor on a computer screen with their thoughts.

The neuroscientists are working closely with computer scientists and robotics experts. The BrainGate2 trial uses two types of robotic arm: the DEKA Arm System, which is being developed for prosthetic limbs in collaboration with US military, and a heavier robot arm being developed by the German Aerospace Centre (DLR) as an external assistive device.

In the latest study, the two participants were given 30 seconds to reach and grasp foam balls. Using the DEKA arm, Bob — who had his stroke in 2006 and was given the neural implant five months before the study —- was able to grasp the targets 62% of the time. Cathy had a 46% success rate with the DEKA arm and a 21% success rate with the DLR arm. She successfully raised the bottled coffee to her lips in four out of six trials.

Nature has published the research paper (citation):

Reach and grasp by people with tetraplegia using a neurally controlled robotic arm

Authors: Leigh R. Hochberg, Daniel Bacher, Beata Jarosiewicz, Nicolas Y. Masse, John D. Simeral, Joern Vogel, Sami Haddadin, Jie Liu, Sydney S. Cash, Patrick van der Smagt and John P. Donoghue

Nature, 485, 372–375 (17 May 2012) doi:10.1038/nature11076

The paper is behind a paywall but if you have access, it’s here.

In the excess emotion after watching that video, I forgot for a moment that the ultimate is to repair soldiers and hopefully get them back into the field.